BTX is committed to creating a world in which patients and families with high unmet medical needs have access to effective treatments.
Employees: 11-50
Founded date: 1994
Investors 1
| Date | Name | Website |
| 06.05.2021 | Disruptive... | disruptive... |
Mentions in press and media 3
| Date | Title | Description |
| 14.06.2021 | Brooklyn ImmunoTherapeutics : Executes Letter of Intent to Buy Novellus Therapeutics | News & Events Brooklyn ImmunoTherapeutics Executes Letter of Intent to Buy Novellus Therapeutics Brooklyn, NY - June 14, 2021 - Brooklyn ImmunoTherapeutics said Monday it has executed a letter of intent to buy Novellus Therapeutics, a c... |
| 15.03.2021 | NTN Buzztime Announces Approval of Merger with Brooklyn ImmunoTherapeutics by Stockholders at Special Meeting | |
| - | COVID-19 vaccines revolutionized RNA — now everyone else wants in | Employees in special suits test procedures for manufacturing the messenger-RNA COVID-19 vaccine from Pfizer-BioNTech in Marburg, Germany, on March 29. Abdulhamid Hosbas/Anadolu Agency via Getty Images This story is available exclusively to ... |